Lupin Limited announced on Thursday the launch of its generic cancer treatment drug in the US market. The Mumbai-based pharmaceutical firm has introduced Doxorubicin Hydrochloride Liposome Injection in single-dose vials. This launch follows the approval from the US Food and Drug Administration (FDA) received by Lupin’s
Aurelle Health, the country’s first D2C Nutraceutical brand aimed at revolutionizing Women’s Hormonal Health, has been launched in India. Aurelle Health’s debut marks a new landmark in the Indian nutraceutical space, with clean, authentic, natural and science-backed supplements based on thorough research and clinically-proven formulations.
“हारेगा डेंगू, हराएंगे हम” campaign launched to spread awareness regarding dengue prevention and control The United States Agency for International Development (USAID) and Takeda Biopharmaceuticals India Private Limited (formerly Baxalta Bioscience India Private Limited) have launched a new campaign called "Haarega Dengue Haraenge Hum (We
Gland Pharma Limited (Gland or Company), a generic injectable-focused pharmaceutical company, has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%. The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Vyzulta® Ophthalmic Solution,
Watch Your Health has announced the completion of a $5 million funding round led by Cornerstone Ventures from India and Conquest Global from Singapore . This capital raise will help the company scale operations and expand the user base both domestically and internationally by growing
The First Indo-Uzbek Pharma Business Forum was successfully held in Hyderabad, Telangana, focusing on trade and investment opportunities in the pharmaceutical sector between India and Uzbekistan. This landmark event was jointly organized by the Embassy of Uzbekistan in New Delhi, the Pharmaceutical Industry Development Agency
The UNICEF order for ceftriaxone supply is an endorsement of Venus Remedies’ exceptional quality standards and its position as a trusted partner in global healthcare supply chains The company also secures a mandate from the world's oldest international public health agency for supplying essential
Wanbury Ltd, one of India’s fast growing pharmaceutical company having a presence in API global market and domestic branded formulation today announced the successful completion of the United States Food & Drug Administration (USFDA) inspection at Patalganga site, Maharashtra. The inspection that started from Monday,
Spearheading the shift towards Pharma 4.0 by leveraging the power of digital Building future-ready pharmaceutical production and biotech facilities to accelerate sustainability, resilience, and, agility Harnessing digital technologies for reducing ~70% CO2 emissions An IoT-enabled solution focused on water conservation, process electrification, sustainability by
Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced that Srinivas Sadu, the incumbent Managing Director (MD) and CEO, has been appointed as Executive Chairman and CEO of the company, effective June 10, 2024. Srinivas Sadu, a seasoned professional with
